Table: Cosmos Pharmaceutical - 9-MTH group results
Apr 11 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Feb 28, 2022 Feb 28, 2021 May 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 558.89 541.70 750.00
(+9.9 pct)
Operating 21.90 26.01 33.20
(+33.8 pct)
Recurring 24.10 27.86 35.90
(+31.4 pct)
Net 16.46 21.58 25.00
(+51.6 pct)
EPS 415.56 yen 545.00 yen 631.33 yen
Ann Div 70.00 yen 80.00 yen
-Q2 div 40.00 yen 27.50 yen
-Q4 div 42.50 yen 40.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T